Codeine and oxycodone use in patients with chronic rheumatic disease pain

Arthritis and Rheumatism

Volumn 41, Issue 9, 1998, Pages 1603-1612

  Ytterberg, Steven R ^a   Mahowald, Maren L ^a,b   Woods, Sharon R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; OXYCODONE;

ADULT; AGED; ANALGESIA; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFICACY; DYSPEPSIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; SEDATION;

AGED; ANALGESICS, OPIOID; CODEINE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; OPIOID-RELATED DISORDERS; OXYCODONE; PAIN; PAIN MEASUREMENT; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES;

EID: 0031681191     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199809)41:9<1603::AID-ART10>3.0.CO;2-U     Document Type: Article

References (60)

1. Gonzales GR, Portenoy RK. Selection of analgesic therapies in rheumatoid arthritis: the role of opioid medications. Arthritis Care Res 1993;6:223-8.
2. Lozada CJ, Altman RD. Management of osteoarthritis. In: WJ Koopman, editor. Arthritis and allied conditions. Baltimore: Williams & Wilkins; 1997. p. 2013-25.
3. Harris ED. Treatment of rheumatoid arthritis. In: Kelley WN, Harris E, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 5th ed. Philadelphia: WB Saunders; 1997. p. 933.
4. Schug SA, Zech D, Grond S, Jung H, Stobbe B. A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage 1992;7:259-66.
5. Portenoy RK. Pain and quality of life: theoretical aspects. In: Osoba D, editor. Quality of life in cancer patients. New York: CRC Publishers; 1991. p. 279-92.
6. Foley KM. Clinical tolerance to opioids. In: Basbaum AI, Besson JM, editors. Towards a new pharmacotherapy of pain. New York: John Wiley & Sons; 1991. p. 181-203.
7. Perry S, Heidrich G. Management of pain during debridement: a survey of US burn units. Pain 1980;13:267-80.
8. Brookoff D, Palmano R. Treating sickle cell pain like cancer pain. Ann Intern Med 1992;116:364-8.
9. Hening WA, Walters A, Kavey N, Gidro-Frank S, Cote L, Fahn S. Dyskinesias while awake and periodic leg movements in sleep in restless legs syndrome: treatment with opioids. Neurology 1996; 36:1363-6.
10. Portenoy RK. Opioid therapy for chronic nonmalignant pain: current status. In: Fields HL, Liebeskind JC, editors. Progress in pain research and management. Vol. 1. Seattle: IASP; 1994. p. 247-87.
11. Katz D, Baptista J, Azen SP, Pile MC. Obtaining confidence intervals for the risk ration in cohort studies. Biometrics 1978;34: 469-74.
12. Traycoff RB. Chronic joint and connective tissue pain. In: Tollison CD, Satterthwaite JR, Tollison JW, editors. Handbook of pain management. Baltimore: Williams & Wilkins; 1994. p. 523-38.
13. Morgan JP. American opiophobia: customary underutilization of opioid analgesics. Adv Alcohol Substance Abuse 1985;5:163-73.
14. Turk DC, Rudy TE. Neglected factors in chronic pain treatment outcome studies - referral patterns, failure to enter treatment, and attrition. Pain 1990;43:7-25.
15. Turk DC, Brody MC, Okifuji EA. Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain 1994;59:201-8.
16. Taylor CB, Zlutnick SI, Corley MJ, Flora J. The effects of detoxification, relaxation and brief supportive therapy on chronic pain. Pain 1980;8:319-29.
17. Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage 1990;5 Suppl:S46-62.
18. Urban BJ, France RD, Steinberger EK, Scott DL, Maltbie AA. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain 1986;24:191-7.
19. Tennant FS, Robinson D, Sagherian A, Seecof R. Chronic opioid treatment of intractable non-malignant pain. NIDA Res Monogr 1988;81:174-80.
20. Zenz M, Strumpf M, Tryba M. Long term oral opioid therapy in patients with chronic non malignant pain. J Pain Symptom Manage 1992;7:69-77.
21. Maruta T, Swanson DW, Finlayson RE. Drug abuse and dependency in patients with chronic pain. Mayo Clin Proc 1979;54: 241-4.
22. Tennant FS, Uelmen GF. Narcotic maintenance for chronic pain: medical and legal guidelines. J Postgrad Med 1983;73:81-94.
23. France RD, Urban BJ, Keefe FJ. Long term use of narcotic analgesics in chronic pain. Soc Sci Med 1984;19:1379-82.
24. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25:171-86.
25. Schofferman J. Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage 1993;8:279-88.
26. Portenoy RK. Opioid therapy in the management of chronic back pain. In: Tollison CD, editor. Interdisciplinary rehabilitation of low back pain. Baltimore: Williams & Wilkins; 1989. p. 137-57.
27. Jamison RN, Anderson KO, Peeters-Asdourian C, Ferrante FM. Survey of opioid use in chronic non-malignant pain patients. Reg Anesth 1994;19:225-30.
28. Gibson T, Clark B. Use of simple analgesics in rheumatoid arthritis. Ann Rheum Dis 1985;44:27-9.
29. Bellamy N, Bradley LA. Workshop on chronic pain, pain control, and patient outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1996;39:357-62.
30. Minor MA, Sanford MK. Physical interventions in the management of pain in arthritis: an overview for research and practice. Arthritis Care Res 1993;6:197-206.
31. Parker JC, Frank RG, Beck NC, Smarr KL, Buescher KL, Phillips LR, et al. Pain management in rheumatoid arthritis patients: a cognitive-behavioral approach. Arthritis Rheum 1988;31:593-601.
32. Parker JC, Iverson GL, Smarr KL, Stucky-Ropp RC. Cognitive-behavioral approaches to pain management in rheumatoid arthritis. Arthritis Care Res 1993;6:207-12.
33. Keefe FJ, Van Horn Y. Cognitive-behavioral treatment of rheumatoid arthritis pain: maintaining treatment gains. Arthritis Care Res 1993;6:213-22.
34. Hardin JG, Kirk KA. Comparative effectiveness of five analgesics for the pain of rheumatoid synovitis. J Rheumatol 1979;6:405-12.
35. Boissier C, Perpoint B, Laporte-Smitsidis S, Mismetti P, Hocquart J, Gayet JL, et al. Acceptability and efficacy of two associations of paracetamol with a central analgesic (dextropropoxyphere or codeine): comparison in osteoarthritis. J Clin Pharmacol 1992;32: 990-5.
36. Kjaersgaard-Andersen P, Nafei A, Skov O, Madsen F. Anderson HM, Krøner K, et al. Codeine plus paracetamol versus paracetamol in longer term treatment of chronic pain due to osteoarthritis of the hip: a randomized, double blind, multi-centre study. Pain 1990;43:309-18.
37. Lloyd RS, Costello F, Eves MJ, James IGV, Miller AJ. The efficacy and tolerability of controlled release dihydrocodeine tablets and combination dextropropoxyphene/paracetamol tablets in patients with severe osteoarthritis of the hips. Curr Med Res Opin 1992;13:37-48.
38. Thurel C, Bardin T, Boccard E. Analgesic efficacy of an association of 500 mg paracetamol plus 30 mg codeine versus 400 mg paracetamol plus 30 mg dextropropoxyphene in repeated doses for chronic lower back pain. Curr Ther Res 1991;50:463-73.
39. Vlok GJ, van Vuren JP. Comparison of a standard ibuprofen treatment regimen with a new ibuprofen/paracetamol/codeine combination in chronic osteoarthritis. S Afr Med J 1987;Suppl 1:1-6.
40. McNairy SL, Maruta T, Ivnik RJ, Swansons DW, Ilstrup DM. Prescription medication dependence and neuropsychologic function. Pain 1984;18:169-77.
41. Hendler N, Cimini C, Ma T, Long D. A comparison of cognitive impairment due to benzodiazepines and to narcotics. Am J Psychiatry 1980;137:828-30.
42. Lowinson JH, Marion IJ, Joseph H, Dole VP. Methadone maintenance. In: Lowinson JH, Ruiz P, Millman RB, editors. Substance abuse: a comprehensive textbook. Baltimore: Williams & Wilkins; 1992. p. 550-61.
43. Brurera E, MacMillan K, Hanson J, MacDonald RN. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 1989;39:13-6.
44. Griffin MR, Brandt KD, Liang MH, Pincus T, Ray WA. Practical management of osteoarthritis. Arch Fam Med 1995;4:1049-55.
45. Shorr RI, Griffin MR, Daugherty JR, Ray WA. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol 1992;47:M111-5.
46. Way EL. Opioid tolerance and physical dependence and their relationship. In: Herz A, editor. Opioids. II. Handbook of experimental pharmacology. Vol. 104. New York: Springer Verlag; 1993. p. 573-95.
47. Colpaert FC, Niemegeers CJE, Janssen PAJ, Maroli AN. The effects of prior fentanyl administrations and of pain on fentanyl analgesia: tolerance to and enhancement of narcotic analgesia. J Pharmacol Exp Ther 1980;213:418-24.
48. Lyness WH, Smith FL, Heavner JE, Iacono CU, Garvin RD. Morphine self-administration in the rat during adjuvant arthritis. Life Sci 1989;45:2217-24.
49. Jasinski DS. Assessment of the abuse potentiality of the morphine-like drugs (methods used in man). In: Martin WR, editor. Handbook of experimental pharmacology: drug addiction. Vol. 45. New York: Springer Verlag; 1977. p. 197-258.
50. Gonzales GR, Elliot KJ, Portenoy RK, Foley KM. The impact of a comprehensive evaluation in the management of cancer pain. Pain 1991;47:141-4.
51. Taub A. Opioid analgesics in the treatment of chronic intractable pain on non-neoplastic origin. In: Kitahata LM, Collins D, editors. Narcotic analgesics in anaesthesiology. Baltimore: Williams & Wilkins; 1982. p. 199-208.
52. Portenoy RK. Opioid tolerance and responsiveness: research findings and clinical observations: proceedings of 7th World Congress on pain. In: Gebhart DF, Hammond DL, Jensen TS, editors. Progress in pain research and management. Vol. 2. Seattle: IASP Press; 1994. p. 595-619.
53. Weissman DE, Haddox JD. Opioid pseudoaddiction: an iatrogenic syndrome. Pain 1989;36:363-4.
54. Sees KL, Clark HW. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage 1993;8:257-64.
55. Wikler A. Opioid dependence: mechanisms and treatment. New York: Plenum Press; 1980.
56. Miotta K, Compton R, Ling W, Conolly M. Diagnosing addictive disease in chronic pain patients. Psychosomatics 1996;1996:223-35.
57. Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence and predictors. Clin J Pain 1997;13:150-5.
58. Clark HW, Sees KL. Opioids, chronic pain and the law. J Pain Symptom Manage 1993;8:297-305.
59. California Legislature. Intractable pain treatment act. Sacramento: California Legislature Service 6475 (West); 1990.
60. Texas Senate. Senate Bill 20. 71st Legislature, 1st Called Sess. (July 18, 1989).